Phase I trial and pharmacokinetic (PK) study of ABT-751, an orally bioavailable tubulin binding agent, in pediatric patients with refractory solid tumors
2004 ◽
Vol 22
(14_suppl)
◽
pp. 2080-2080
◽
Keyword(s):
Phase I
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 13532-13532
2004 ◽
Vol 10
(3)
◽
pp. 840-848
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 9500-9500
◽